Quarterly report pursuant to Section 13 or 15(d)

Note 17 - Stockholders' Equity - Summary of Warrant Activity (Details)

v3.21.2
Note 17 - Stockholders' Equity - Summary of Warrant Activity (Details)
9 Months Ended
Aug. 31, 2021
$ / shares
shares
Outstanding, beginning balance (in shares) | shares 585,739
Outstanding, beginning balance, weighted average exercise price (in dollars per share) | $ / shares $ 2.40
Exercised (in shares) | shares (510,739)
Exercised, weighted average exercise price (in dollars per share) | $ / shares $ 2.50
Outstanding, ending balance (in shares) | shares 75,000
Outstanding, ending balance, weighted average exercise price (in dollars per share) | $ / shares $ 1.55
Exercisable (in shares) | shares 75,000
Exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 1.55